HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors

SIMPLE SUMMARY: Epidermal growth factor receptor (EGFR) is one of the anticancer drug targets for certain malignancies including nonsmall cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma. However, the grave issue of drug resistance through diverse mechanis...

Descripción completa

Detalles Bibliográficos
Autor principal: Yonesaka, Kimio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958627/
https://www.ncbi.nlm.nih.gov/pubmed/33801379
http://dx.doi.org/10.3390/cancers13051047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958627/
https://www.ncbi.nlm.nih.gov/pubmed/33801379
http://dx.doi.org/10.3390/cancers13051047

Ejemplares similares